Study of essential hypertension with special reference to end organ damage in adults


  • Rukmini Ramya M. Department of General Medicine, Rangaraya Medical College, Kakinada, Andhra Pradesh, India
  • Rajya Lakshmi M. Department of General Medicine, Rangaraya Medical College, Kakinada, Andhra Pradesh, India



Essential hypertension, End organ damage, Risk factors


Background: Hypertension, a major public health concern, affecting 20-25% of the adult population. It is the major risk factor for diseases involving Cardio Vascular (CV) and renal

system. The World Health Organization (WHO) has estimated that high Blood Pressure (BP) causes 1 in every 8 deaths, making hypertension the third leading killer in the world. The recent emerging trend in the treatment of hypertension is not only based on the pragmatic need to lower BP levels, but also on lowering the CV risk profile, which is largely linked to the presence of the end organ damage.

Methods: One hundred patients with hypertension are recruited in this study. The ethics committee of Rangaraya Medical College, Kakinada approved this study and all the participants provided informed consent for all the procedures in the study protocol.

Results: Majority of the patients (40%) with EOD have hypertension of >10 years duration. The relative frequency of various end organ damages (CVS: 34%, CNS: 17%, kidney: 12% and eye: 10%) is also high in patients with hypertension of >10 years duration.

Conclusions: A significant proportion of hypertensive subjects had documented associated EOD, with LVH being the most prevalent EOD. The above findings emphasize the important role of the primary care clinicians to the early detection, treatment and control of high blood pressure that might help to reducing overall cardiovascular risk.


Tocci G, Volpe M. End-organ protection in patients with hypertension. Drugs. 2011 May 1;71(8):1003-17.

Sawhney JP. First orally active DRI Aliskiren-a new prospect in management of hypertension and beyond. Indian Heart J. 2010;62(1):49-56.

Al-Duwaisan HS, Al-Mhza AM, Al-Yaha AA, Al-Qattan MM. Assessment of target organ damage in hypertension through a clinical audit in Kuwait family practice. Kuwait Med J. 2003;35:202-7.

Shanthirani CS, Pradeepa R, Deepa R, Premalatha G, Saroja R, Mohan V. Prevalence and risk factors of hypertension in a selected South Indian population-the Chennai Urban Population Study. J Assoc Physicians India. 2003 Jan 1;51:20-7.

Gupta R, Guptha S, Gupta VP, Prakash H. Prevalence and determinants of hypertension in the urban population of Jaipur in western India. J Hypertens. 1995 Oct;13(10):1193-200.

Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N. Prevalence, awareness and treatment status of hypertension in urban population of Delhi. Indian J Med Res. 1990 Aug;92:233-40.

Reddy SS, Prabhu GR. Prevalence and risk factors of hypertension in adults in an Urban Slum, Tirupati, AP. Indian J Comm Med. 2005 Jul 1;30(3):84.

Kulkarni V, Bhagwat N, Hakim A, Kamath S, Soneji SL. Hypertension in the Elderly. J Assoc Physicians India. 2001 Sep;49:873-6.

Chowta NK, Sundeep S, Chowta MN. Comparative Study of Clinical Profile of Elderly and Young Hypertensives. Indian J Practising Doctor. 2009;5(6):41-5.

Anand MP. Epidemiology of hypertension. In: Current Concepts in Hypertension, 1st Edition, Sainani GS(Ed) ICP Mumbai. 1995; 4-13.

Malhotra P, Kumari S, Kumar R, Jain S, Sharma BK. Prevalence and determinants of hypertension in an un-industrialised rural population of North India. J Hum Hypertens. 1999 Jul;13(7):467.

Anand MP. Prevalence of hypertension in India. Indian Heart J. 2010;62:388-93.

Qi WH, Pan CY, Lin SY. A survey of factors influencing prognosis and control rate for patients with hypertension in mainland China. Zhonghua xin xue guan bing za zhi. 2007 May;35(5):457-60.

Ayodele OE, Alebiosu CO, Akinwusi PO, Akinsola A, Mejiuni A. Target organ damage and associated clinical conditions in newly diagnosed hypertensives attending a tertiary health facility. Nigerian J Clin Pract. 2007;10(4):319-25.

Ayodele OE, Alebiosu CO, Salako BL, Awodein OG, Adigun AD. Target organ damage and associated clinical conditions among Nigerians with treated hypertension: cardiovascular topic. Cardiovas J South Africa. 2005 Mar 1;16(2):89-93.

Addo J, Smeeth L, Leon DA. Hypertensive target organ damage in Ghanaian civil servants with hypertension. PloS One. 2009 Aug 18;4(8):e6672.

Oladapo OO, Salako L, Sadiq L, Shoyinka K, Adedapo K, Falase AO. Target-organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study. Cardiovas J Africa. 2012 Aug;23(7):379.

Njoh J. Complications of hypertension in adult urban Liberians. J Hum Hypertens. 1990 Apr;4(2):88-90.

Dwivedi S, Singh G, Agarwal MP. Profile of hypertension in elderly subjects. J Assoc Physicians India. 2000;48(11):1047-9.

Bertomeu V, Fácila L, González-Juanatey JR, Cea-Calvo L, Aznar J, et al. Blood pressure control in hypertensive patients with left ventricular hypertrophy. The VIIDA Study. Spanish J Cardiol. 2007 Dec 1;60(12):1257-63.

Cui H, Fan L, Zhang M, Ye P, Dai W, Liu GS. Incidence and risk factors of target organ damage in 17, 682 elderly hypertensive inpatients between 1993 and 2008. Zhonghua xin xue guan bing za zhi. 2012 Apr;40(4):307-12.

Cuspidi C, Valerio C, Sala C, Esposito A, Masaidi M, Negri F, et al. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure. Blood Pressure Monitoring. 2008 Feb 1;13(1):7-13.

Hussain AA, Elzubier AG, Ahmed ME. Target organ involvement in hypertensive patients in Eastern Sudan. J Hum Hypertens. 1999 Jan;13(1):9.

Ohta Y, Tsuchihashi T, Kiyohara K. Influence of salt intake on target organ damages in treated hypertensive patients. Clin Experiment Hypertens. 2012 Aug 1;34(5):316-20.

Yilmaz R, Akoglu H, Altun B, Yildirim T, Arici M, Erdem Y. Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients. Eur J Clin Nutr. 2012 Nov;66(11):1214.

Du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens. 2002 Mar 1;15(3):222-9.






Original Research Articles